Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Ex Vivo Fluorescence Confocal Microscopy for Real-Time Margin Assessment of Nonmelanoma Skin Cancer in Mohs Surgery: A Prospective Interventional Study
Marco Spadafora; Serena Morsia; Margherita Raucci; Shaniko Kaleci; Johanna Chester; Cinzia Ricci; Simonetta Piana; Giovanni Pellacani; Moira Ragazzi; Caterina LongoShow moreShow less
Department of Surgery, Medicine, Dental Medicine and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy; Department of Dermatology, Azienda Ospedaliero-Universitaria Policlinico di Modena, Italy; Skin Cancer Center, Azienda Unità Sanitaria Locale–IRCCS di Reggio Emilia, Italy; Pathology Unit, Azienda Unità Sanitaria Locale–IRCCS di Reggio Emilia, Italy; Department of Clinical, Anesthesiological and Cardiovascular Sciences, Dermatology Clinic, Sapienza University of Rome, Rome, Italy; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, ItalyShow moreShow less
Immunohistochemistry Resolves Indeterminate MTAP Deletion Calls From Exome Sequencing: A Pan-Cancer Concordance Study
Marion Thibaudin; Julie Lecuelle; Anthony Bergeron; Valentin Derangère; Hugo Mananet; Léa Hampe; Susy Daumoine; Sandy Chevrier; Ana Costa; Natacha Moulharat; Maria-Elisabetta Serrentino; Françoise Beltjens; Paul Hofman; Romain Boidot; Alis Ilié; David Rageot; Caroline Truntzer; Laurent Arnould; Francois GhiringhelliShow moreShow less
Université Bourgogne Europe, Centre de Lutte Contre le Cancer G.-F. Leclerc, Plateforme de Transfert en Biologie du Cancer, INSERM, CTM UMR 1231, Equipe TIRECS, Dijon, France; Université Bourgogne Europe, Centre de Lutte Contre le Cancer G.-F. Leclerc, Département de Biologie et Pathologie des Tumeurs, Dijon, France; Institut Servier de Medecine Translationnelle, Gif-sur-Yvette, France; Medical Affairs- Servier, Suresnes, France; IHU RespirERA, Laboratory of Clinical and Experimental Pathology, Hospital-Integrated Biobank (BB-0033-00025), FHU OncoAge, Institute for Research on Ageing and Cancer Nice (IRCAN), University Hospital Centre Nice, University Côte d’Azur, Nice, France; Université Bourgogne Europe, Centre de Lutte Contre le Cancer G.-F. Leclerc, Département d’Oncologie Médicale, INSERM, CTM UMR 1231, Equipe TIRECS, Dijon, FranceShow moreShow less
Bile Duct–Narrowing Neuroendocrine Tumors Show a PDX1+/CDX2+ Phenotype Resembling Duodenal Rather Than Pancreatic Neuroendocrine Tumors
Atsuko Kasajima; Ayako Ura; Katja Evert; Matthias Evert; Bruno Märkl; Elisa Moser; Katja Steiger; Carolin Mogler; Ihsan Ekin Demir; Marc Martignoni; Matthias Eiber; Alexander von Werder; Helmut Friess; Günter KlöppelShow moreShow less
Department of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany; Bavarian Center for Cancer Research (BZKF), Munich, Germany; Institute of Pathology, University of Regensburg, Regensburg, Germany; Institute of Pathology, Medical Faculty, University of Augsburg, Augsburg, Germany; Department of Surgery, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany; Department of Internal Medicine II, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany; Department of Nuclear Medicine, TUM School of Medicine and Health, Technical University of Munich, Munich, GermanyShow moreShow less
Comparison of Albumin In Situ Hybridization in Genetically Characterized Cholangiocarcinoma and Tumors of Other Origins
Jay Shi; Sahar Hosseini; Evan Lang; Charlotte I. Wang; Linda T. Nieman; Vikram Desphande; David Ting; Lei ZhaoShow moreShow less
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts; Mass General Brigham Cancer Institute, Harvard Medical School, Charlestown, Massachusetts; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MassachusettsShow moreShow less
A Transcriptional ILCness Score Reveals Lobular-like Biology and Clinical Behavior Beyond CDH1 Mutation Status
Masanori Oshi; Sasagu Kurozumi; Mayu Hizume; Akimitsu Yamada; Zunairah Shah; Itaru Endo; Kazuaki TakabeShow moreShow less
Department of Breast Surgery, Yokohama City University Hospital, Yokohama, Japan; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York; Department of Breast and Thyroid Surgery, Gunma University, Gunma, Japan; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York; Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; Department of Breast Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan; Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, State University of New York, Buffalo, New YorkShow moreShow less
Integrated Bulk and Spatial Proteomics of Castleman Disease: Molecular Signatures Across Subtypes and Compartmentalized Pathogenic Networks in Idiopathic Multicentric Castleman disease (iMCD)–Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO)
Shuang Zheng; Yu Huang; Xinyi Huang; Shuqi Li; Wenhui Zhang; Zheng Yang; Qinghua CaoShow moreShow less
Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Department of Pathology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China; Department of Pathology, Chinese Academy of Medical Sciences & Peking Union Medical College Plastic Surgery Hospital and Institute, Shijingshan District, Beijing, China; Department of Pathology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, ChinaShow moreShow less
FAQ
How long does MODERN PATHOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for MODERN PATHOLOGY. The fastest paper went from submission to acceptance in 40 days (Lung Carcinoids with Sustentacular Cells and Low Keratin Expression: A Common yet Underrecognized Phenomenon with Diagnostic and Biological Implications, received 2026-05-19, accepted 2026-06-28); the slowest took 257 days. The average is 133.7 days and the median is 127 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
